Search for content, post, videos

Pelago Bioscience, AstraZeneca enter agreement

agreement
Pelago Bioscience AB and AstraZeneca have entered into a 2-year strategic research collaboration and license agreement. The companies will collaborate on specified joint projects and AstraZeneca will also be granted a license to use and apply the Cellular Thermal Shift Assay (CETSA®) for determ
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.